Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 500% increase over the number of companies inspected in the previous quarter, when one company received one inspection.
The companies inspected were involved in either the Food and Cosmetics or Biologics sectors.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Amerisource Bergen Corporation | Food and Cosmetics | 07/25/2024 | No Action Indicated (NAI) |
| Center for Reproductive Medicine | Biologics | 09/19/2024 | No Action Indicated (NAI) |
| ORMC Hospital Laboratory | Biologics | 09/18/2024 | No Action Indicated (NAI) |
| OneBlood, Inc. | Biologics | 07/25/2024 | No Action Indicated (NAI) |
| The Coca-Cola Company | Food and Cosmetics | 07/17/2024 | No Action Indicated (NAI) |
| XYMOGEN, Inc. | Food and Cosmetics | 08/13/2024 | Voluntary Action Indicated (VAI) |
Alerts Sign-up